Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wang Liu

Showing results (431-440 of 435) with videos related to

Pageof 44
Sort By:
You have reached the last page of results.This site can display upto 435 results.
Molecular Pharmacology|May 19, 2006
Transforming growth factor-beta receptor type 1 (TGFbetaRI) kinase activity but not p38 activation is required for TGFbetaRI-induced myofibroblast differentiation and profibrotic gene expressionAnn M Kapoun, Nicholas J Gaspar, Ying Wang, et al.
Pharmacology|January 8, 2008
Pharmacological properties of SD-282 - an alpha-isoform selective inhibitor for p38 MAP kinaseBruce Koppelman, Heather K Webb, Satyanarayana Medicherla, et al.
Nature|May 11, 2017
Intratumoural heterogeneity generated by Notch signalling promotes small-cell lung cancerJing Shan Lim, Alvaro Ibaseta, Marcus M Fischer, et al.
Oncogene|June 19, 2026
A cholesterol-dependent LRRC8A-caveolin-1 axis sustains KRAS/EGFR signaling, ribosome biogenesis and growth in pancreatic ductal adenocarcinomaQing Ye, Hong-Zhi Liu, Xiao-Qi Wang, et al.
Nature Immunology|October 31, 2023
E-selectin-mediated rapid NLRP3 inflammasome activation regulates S100A8/S100A9 release from neutrophils via transient gasdermin D pore formationMonika Pruenster, Roland Immler, Jonas Roth, et al.
Pageof 44

Showing results (431-440 of 435) with videos related to

Sort By:
Pageof 44
You have reached the last page of results.This site can display upto 435 results.
Molecular Pharmacology|May 19, 2006
Transforming growth factor-beta receptor type 1 (TGFbetaRI) kinase activity but not p38 activation is required for TGFbetaRI-induced myofibroblast differentiation and profibrotic gene expressionAnn M Kapoun, Nicholas J Gaspar, Ying Wang, et al.
Pharmacology|January 8, 2008
Pharmacological properties of SD-282 - an alpha-isoform selective inhibitor for p38 MAP kinaseBruce Koppelman, Heather K Webb, Satyanarayana Medicherla, et al.
Nature|May 11, 2017
Intratumoural heterogeneity generated by Notch signalling promotes small-cell lung cancerJing Shan Lim, Alvaro Ibaseta, Marcus M Fischer, et al.
Oncogene|June 19, 2026
A cholesterol-dependent LRRC8A-caveolin-1 axis sustains KRAS/EGFR signaling, ribosome biogenesis and growth in pancreatic ductal adenocarcinomaQing Ye, Hong-Zhi Liu, Xiao-Qi Wang, et al.
Nature Immunology|October 31, 2023
E-selectin-mediated rapid NLRP3 inflammasome activation regulates S100A8/S100A9 release from neutrophils via transient gasdermin D pore formationMonika Pruenster, Roland Immler, Jonas Roth, et al.
Pageof 44